Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual public listening meeting to solicit input on methods and approaches (e.g., use of real-world evidence (RWE), registries) for capturing post approval safety and efficacy data for cell and gene therapy products.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/vRF2xgO
No comments:
Post a Comment